• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 18 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1325
L-ergothioneine produced by Escherichia coli SF4012 expressing enzymes encoded by the genes from E. coli BL21 (DE3), Leishmania infantum, Mycobacterium tuberculosis, Neurospora crassa, Trichoderma reesei, and Mycolicibacterium smegmatis Pending
  1141
L-α-glycerophosphorylcholine Apr 29, 2024 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (89 kB)
  913
Algal oil (minimum 35% DHA) Nov 10, 2020 FDA has no questions; some uses may require a color additive listing (in PDF) (906 kB)
  778
Hemp seed oil Dec 20, 2018 FDA has no questions (in PDF) (434 kB) Feb 10, 2020
  771
Hemp seed protein Dec 20, 2018 FDA has no questions (in PDF) (484 kB) Feb 10, 2020
  765
Dehulled hemp seed Dec 20, 2018 FDA has no questions (in PDF) (278 kB) Feb 10, 2020
  649
β-galactosidase enzyme preparation from Bacillus circulans produced in Bacillus subtilis Nov 28, 2016 FDA has no questions
  507
Amylomaltase enzyme preparation from Bacillus amyloliquefaciens carrying an amylomaltase gene from Thermus thermophiles Sep 11, 2014 FDA has no questions
  501
L-theanine (chemically synthesized) Jul 30, 2014 FDA has no questions
  493
High purity steviol glycosides (minimum purity 95%) May 30, 2014 FDA has no questions
  489
Galacto-oligosaccharides May 22, 2014 FDA has no questions
  484
Galacto-oligosaccharides May 8, 2014 FDA has no questions
  480
Dried aqueous extract derived from white kidney bean (Phaseolus vulgaris)
   (Resubmission of GRN 434)
May 30, 2014 FDA has no questions
  401
Erythritol Mar 22, 2012 FDA has no questions
  286
Galacto-oligosaccharides Sep 4, 2009 FDA has no questions Jan 6, 2015
Apr 15, 2011
  285
Galacto-oligosaccharides Sep 4, 2009 FDA has no questions Jan 6, 2015
Apr 15, 2011
  223
Phosphatidylserine Dec 20, 2007 FDA has no questions
  19
Ferrous bisglycinate chelate Sep 30, 1999 FDA has no questions

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-